If there’s anything that Dr. Vinay Prasad, the controversial new appointee to lead the Center for Biologics Evaluation and Research, or CBER, a top office at the Food and Drug Administration, loves to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

He completed the journey of visiting every country on Earth in just 6 years, 6 months and 22 days.

Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), has stepped down, with market analysts forecasting a boost to the cell and ...

Prasad left the agency after far-right influencer released edited audio misleadingly suggesting he was anti-Trump Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood ...

(Bloomberg) -- Vinay Prasad, a top regulator at the US Food and Drug Administration, ended his short tenure at the agency after conservative pundits including Laura Loomer and Rick Santorum led a ...

Dr Vinay Prasad, previously ousted from his FDA vaccine chief position due to criticism from Laura Loomer over past anti-Trump comments and drug approval decisions, has been reinstated. This unusual ...

India's film restoration ecosystem has got a boost after Prasad Corp entered allaince with Monsoon Colour Lab aimed at ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

Vinay Prasad, outspoken critic of pharmaceutical industry and of his peers in public health, to take over CBER Vinay Prasad, an oncologist and hematologist who has called for more regulatory scrutiny ...